Wave Life Sciences (WVE) Exchange Rate Effect (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Exchange Rate Effect came in at $123000.0 in Q2 2026, up 186.05% YoY from $43000.0 in Q2 2025, and up 3175.0% on a QoQ basis from -$4000.0 in Q1 2026.
Powered by 
Analysis
Wave Life Sciences (WVE) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of Exchange Rate Effect data on file, last reported at $123000.0 in Q2 2026.
- Quarterly Exchange Rate Effect rose 186.05% year-over-year to $123000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $30000.0 (down 74.58% YoY) and the FY2025 annual result came in at $12000.0, up 108.7% from the prior year.
- Exchange Rate Effect rose to $123000.0 in Q2 2026, from -$4000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $123000.0 in Q2 2026 to a low of -$142000.0 in Q2 2022.
- A 5-year average of -$17333.3 and a median of -$30500.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 590.91% — and 2024, when it soared 475.0%.
- Tracing WVE's Exchange Rate Effect over 5 years: stood at $94000.0 in 2022, then slumped by 38.3% to $58000.0 in 2023, then plunged by 277.59% to -$103000.0 in 2024, then surged by 41.75% to -$60000.0 in 2025, then jumped by 305.0% to $123000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $123000.0 (Q2 2026), -$4000.0 (Q1 2026), and -$60000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Wave Life Sciences | 994.54 Mn | 626.53 Mn | - | 123,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123,000.00 |
| Mar 31, 2026 | -4,000.00 |
| Dec 31, 2025 | -60,000.00 |
| Sep 30, 2025 | -29,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | -103,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | -81,000.00 |
| Mar 31, 2024 | -74,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | -32,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Dec 31, 2022 | 94,000.00 |
| Sep 30, 2022 | -76,000.00 |
| Jun 30, 2022 | -142,000.00 |
| Mar 31, 2022 | -86,000.00 |
| Dec 31, 2021 | -77,000.00 |
| Sep 30, 2021 | -11,000.00 |